Early-career Cancer Researchers Interview NCI Director Kimryn Rathmell
NCI Director Kimryn Rathmell shared advice for the next generation of cancer researchers with members of the AACR Associate...
NCI Director Kimryn Rathmell shared advice for the next generation of cancer researchers with members of the AACR Associate...
Dr. Edward Cliff presented a poster on the clinical benefit of cancer drugs granted accelerated approval.
The AACR Annual Meeting 2024 Opening Ceremony showcased impactful initiatives impacting cancer research.
A special issue of Cancer Discovery illustrates the vast landscape of research being explored within the AACR community.
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
A few important details to help attendees get the most out of their experience at the AACR Annual Meeting...
AACRoC in Brazil let young investigators learn from cancer research experts during programs in São Paulo and Ribeirão Preto.
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
Three patients share their experiences about having Lynch syndrome.
Researchers are exploring new options for kidney cancer treatments.
The AACR-Women in Cancer Research constituency group celebrates its 25th anniversary this year.